Vaccination considerations in the asplenic patient.
Overwhelming postsplenectomy sepsis is a rare but devastating and often lethal disease. Although vaccines are available, their proper use may be questioned. Standardization of protocols for the immunization of asplenic patients should be universal, thus, likely improving on their use. This article reviews the vaccines to be administered to the asplenic patient.
Shatz
David V
DV
Department of Surgery, Division of Trauma, Burns, and Surgical Critical Care, University of Miami School of Medicine, PO Box 016960 (D-40), Miami, FL 33101, USA. dshatz@miami.edu
D000328:Adult; D016667:Bacterial Capsules; D002675:Child, Preschool; D018073:Haemophilus Vaccines; D006801:Humans; D007223:Infant; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial; D011183:Postoperative Complications / Q000382:microbiology / Q000517:prevention & control*; D018805:Sepsis / Q000382:microbiology / Q000517:prevention & control*; D013156:Splenectomy; D013997:Time Factors; D014611:Vaccination
C414006:23-valent pneumococcal capsular polysaccharide vaccine; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines; D011135:Polysaccharides, Bacterial